Abstract
Injudicious use of antibiotics escalates the cost of stone treatment, besides encouraging the development of resistant strains of bacteria, which then require third generation antibiotics for eradication. A course of injectable, third generation cephalosporins for seven days (US$ 210) may cost approximately a third of the cost of lithotripsy (US$ 500–600). Injectable antibiotics sometimes require admission, because of the lack of domiciliary services, which further add to the costs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Coe EL, Favus MJ. Nephrolithiasis. In: Wilson et al., editors. Harrison’s principles of internal medicine. New York: McGraw-Hill, 1991:1205.
Becopoulos T, Tsagatakis E, Constantinides C et al. Ureaplasma urealyticum and infected renal calculi. J Chemother 1991;3:39–41.
Griffith DL. Struvite stones: Is chemoprophylaxis necessary? In: Giuliani L, Puppo P, editors. Controversies on the management of urinary stone. Basel: Karger, 1988:235–8.
Edin-Liljegren A, Grenabo L, Hedelin H et al. The influence of pH and urinary composition on urease enzymatic activity in human urine. Urol Res 1992;20:35–9.
Hess B. Prophylaxis of infection induced kidney stone formation. Urol Res 1990;18:45–8.
Rizvi SAH. The problem of urolithiasis in Pakistan. J Pak Med Assoc 1975;25:276–8.
Rizvi SAH. Calculous disease: A survey of 400 patients. J Pak Med Assoc 1975;25:268–74.
Farooqui S, Nasir A, Naqvi AJ. Analysis of 1423 new patients referred to the nephrourology department of the PMC Karachi. A 5 year study. J Pak Med Assoc 1975;25:286–8.
Parkash, Fayyaz, Farhat et al. Urolithiasis in children. Abstracts of the First International Symposium of the SIUT, Pakistan, Karachi 1995:F5.
Ohkawa M, Tokunaga S, Nakashima T et al. Composition of urinary calculi related to urinary tract infection. J Urol 1992;148:995–7.
Shigeta M, Yamasaki A, Hayashi M. A clinical study in upper urinary tract calculi treated with ESWL monotherapy with regard to bacteriuria before ESWL. Nippon Hinyokika Gakkai Zasshi 1993;84:866–72.
Oka T, Nishimura K, Tsujimura A et al. Influences of bacteria within stones on ESWL treatment. Hinyokika Kiyo 1992;38:999–1003.
Vogel E, Eusterbrock M, Leskovar P. Recurrence rates of phosphate stones after open surgery and PCN. Uro Res 1987;15:128.
Castillo-Rodriguez M, Larria-Masoidal E, Garcia-Serrano C et al. Staghorn calculi, combined treatment with PCNL and ESWL. Arch Esp Urol 1993;46:699–706.
Buck AC. The use of noxythiolin as an antiseptic agent in upper urinary tract drainage following percutaneous nephrolithotomy. Br J Urol 1988;62:306–10.
Reid G, Jewett MA, Nickel JC et al. Effect of ESWL on bacterial viability. Urol Res 1990;18:425–7.
Michels EK, Fowler JE. ESWL for struvite renal calculi; prospective study with extended followup. J Urol 1991;146:728–32.
Raz R, Zoabi A, Sudarsky M et al. The incidence of UTI in patients without bacteriuria, who underwent ESWL. J Urol 1994;32:30.
Gasser TC, Frei R. Risk of bacteraemia during ESWL. Br J Urol 1993;71:17–20.
Muller-Mathias VG, Schmale D, Seewald M et al. Bacteremia during ESWL of renal calculi. J Urol 1991;146:733–6.
Orenstein R, Bross JE, Dahlman M. Risk factors for urinary lithotripsy associated sepsis. Infection Control Hosp Epidemiol 1993;14:469–72.
Kattan S, Hussain I, El-Faqih SR et al. Incidence of bacteremia and bacteriuria in patients with non-infection related stones undergoing ESWL. J Endourol 1993;7:449–51.
Peterson B, Tiselius HG. Are prophylactic antibiotics necessary during ESWL? Br J Urol 1989;63:449–52.
Pode D, Lenokovsky Z, Shapiro A et al. Can ESWL eradicate persistent UTI associated with infected stones? J Urol 1988;140:257–9.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Talati, J. (1997). Urinary tract infection, stones and ESWL. In: Talati, J., Sutton, R.A.L., Moazam, F., Ahmed, M. (eds) The Management of Lithiasis. Developments in Nephrology, vol 38. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5396-6_30
Download citation
DOI: https://doi.org/10.1007/978-94-011-5396-6_30
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6270-1
Online ISBN: 978-94-011-5396-6
eBook Packages: Springer Book Archive